CSI Market
Sign In | Register

Bio Green Med Solution Inc (BGMS) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BGMS Annual Cash Flow →
The data below summarizes Bio Green Med Solution Inc's cash flow activity from Jun 30 2025 to Jun 30 2026, enabling a period-by-period view of cash movement.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-1.24
Depreciation & amortization0.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.54
Increase (Decrease) in Inventories-0.41
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.02
Investment Income Amortization Of Premium-
Change In Valuation Of Warrants Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities-
Gain Loss On Price Risk Derivatives Net-
Stock Option Plan Expenses-
Issuance Of Stocks And Warrants For Services Or Claims-
Transaction Costs On Sale Of Economic Rights-
Change In Valuation Of Liabilities Measured At Fair Value-
Increase Decrease In Operating Lease Liability0.00
Increase Decrease In Prepaid Expenses And Other Assets-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.18
Increase (Decrease) in Accounts Payable and Other Operating Liabilities-0.64
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.02
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities1.30
Discontinued operations0.00
Net Cash flow from Operating Activities-0.63
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.92
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Issuance Of Common Stock And Warrant Exercises Net Of Issuance Costs-
Proceeds From Exercise Of Stock Options And Warrant Exercises Net Of Issuance Costs-
Proceeds From Exercise Of Stock Options And Warrants Net Of Issuance Costs-
Costs From Issuing Common Stock And Prefunded Warrants-
Payments of Ordinary Dividends, Preferred Stock and Preference Stock-0.04
Dividends paid0.00
Net Cash Flow from Financing Activities0.88
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.63
Total Cash Flow0.29
4 historic quarters locked

Sign in to unlock the full Bio Green Med Solution Inc cash flow history.

Sign In Create Free Account

About Bio Green Med Solution Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 14, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-038393

Figures are derived from filed reports and may be restated. Historical data is subject to revision.